Skip to main content
. 2021 Jan 12;34(2):108615. doi: 10.1016/j.celrep.2020.108615
PM delay AAO AAD Duration Gender Clinical Diag Path Diag Brain Weight Mutations APOE Braak Tau Thal Phase CERAD ABC CAA
Control 16:15:00 na 88 na M Control Path Aging 1077 Control 1 33 2 2 B1 0
Control 76:10:00 na 71 na F Control low level AD changes 1214 Control 2 33 3 2 0 A1B2C0 1
Control 47:05:00 na 89 na M Control Control 1356 Control 3 33 2 3 1 A2B1C1 1
Control 59:57:00 na 96 na F Control Control 1032 Control 4 33 2 2 0 A1B1C0 1
Control 38:00:00 na 96 na F Control Control 1092 Control 5 2 1 0 A1B1C0 1
fAD 32:10:00 49 62 13 M fAD fAD 1302 APP V717L 44 6 5 3 A3B3C3 3
fAD 68:05:00 60 66 6 M AD fAD 1437 APP V717I 33 6 5 3 A3B3C3 1
fAD 43:10:00 42 51 9 M fAD fAD 1415 PSEN1 int4del 33 6 5 3 A3B3C3 3
fAD 128:35:00 41 49 8 F fAD fAD 1205 PSEN1 M139V 33 6 5 3 A3B3C3 2
fAD 77:45:00 51 66 15 M fAD fAD 1106 PSEN1 R278I 23 6 5 3 A3B3C3 3
fAD 11:00:00 42 53 11 F fAD fAD 994 PSEN1 E280G 34 6 5 3 A3B3C3 3
fAD 43:50:00 42 47 5 M MSA fAD 1225 PSEN1 A434T & T291A 33 5 5 3 A3B3C3 3